Introduction
This review follows the pattern of its predecessors in being a description of various topics in virological research for which particularly noteworthy advances were published in or around 1989. As before, it is a highly selective account, which reflects the interests of the authors. The review starts with a description of a newly characterized agent of viral hepatitis, followed by two aspects of work on human immunodeficiency virus (HIV). The following sections then treat aspects of genome structure and genetic content, gene expression, viral protein function, virion structure and virus-cell interactions, and finish with a short section on the nature of spongiform encephalitic disease.
Hepatitis C virus
The year 1989 saw a major advance in the field of viral hepatitis with the identification of a virus responsible for a large proportion of non-A, non-B hepatitis (NANBH). It had become apparent when specific diagnostic reagents for hepatitis A virus (a picornavirus) and hepatitis B virus (a hepadnavirus) were developed that most cases of post-transfusion hepatitis were not caused by these agents or by any other known hepatotropic viruses. In the United States alone NANBH affects 200000 to 300000 people per annum, and up to 10% of blood transfusions result in NANBH. Acute infection is often subclinical, but about 50% of NANBH cases develop chronic liver disease (Dienstag & Alter, 1986) . Despite considerable research effort the agent or agents responsible for NANBH remained unidentified though evidence was obtained to suggest that a small enveloped virus, possibly a togavirus, could transmit the disease to chimpanzees (reviewed by Bradley, 1985) . Choo et al. (1989) , based at the Chiron Corporation in California, applied recombinant DNA technology in a t Member of the MRC Virology Unit. masterly fashion to identify the agent of NANBH. It is worth considering their approach in detail since it should be applicable to the isolation of other unidentified agents. The starting material was plasma from a chimpanzee, which contained a high infectious titre. This was subjected to ultracentrifugation sufficient to pellet a small virus and the nucleic acids were extracted. As the nature of the genetic material of the agent was unknown, cDNA was prepared from total nucleic acids using random oligonucleotide primers and reverse transcriptase. The cDNA was cloned into 2gtl 1, to allow expression of cDNA-encoded proteins. Approximately 1 million recombinant clones were screened by immunoblotting using serum from a chronic NANBH patient as a source of specific antibodies, and a clone was identified which expressed an antigen specific for NANBH infections. Other overlapping clones in the 2 library were identified using the first clone as a probe. By use of strand-specific probes the genome of the infectious agent was determined to be a single-stranded RNA about 10 kb in length; cDNA hybridization and sequence data then allowed the genome to be assigned as the positive strand. This is consistent with the virus belonging to the toga-or flavivirus families. The agent was named hepatitis C virus (HCV).
In an accompanying paper Kuo et al. (1989) described the development of an efficient immunological assay for the detection of HCV antibodies in plasma based on the expression of HCV cDNA in yeast. This has now been widely used to screen plasma of NANBH patients and the results indicate that HCV is associated with most post-transfusion NANBH (e.g. Bruix et al., 1989; Colombo et al., 1989; Esteban et al., 1989; Kuo et al., 1989; van der Poel et al., 1989) . These studies provide overwhelming evidence that routine screening of donated blood for HCV antibodies should greatly reduce the incidence of NANBH. Kubo et al. (1989) have recently isolated a cDNA clone of HCV from a patient who was initially identified as HCV-positive by the immunoassay. RNA was extracted from the patient's plasma and cDNA prepared and 0000-9634 © 1990 SGM amplified by the polymerase chain reaction (PCR) using oligonucleotide primers based on the 'prototype' HCV sequence. The amplified cDNA fragment of 583 nucleotides showed 79.8~ identity with the chimpanzeederived HCV. Thus a major area for further work will be to establish the degree of variation among different HCV isolates, which should lead to the generation of better diagnostic reagents.
The identification of HCV has been a major achievement in virology. However, the work has large commercial implications in terms of diagnostic reagents and ultimately a vaccine. In our perception this factor has had an unfortunate effect in restricting fundamental information about this important human disease agent and in delaying its further characterization. To the best of our knowledge the genomic nucleotide sequence is at the time of writing this review (February 1990 ) still accessible only via patent applications (e.g. Chiron Corporation, 1989) .
HIV
Reviewing work on HIV and AIDS has become quite difficult in view of the intense activities in many aspects of this field. For 1989 we chose to concentrate on two aspects of HIV research, namely the analysis of drugresistant mutants of the virus (in this section) and structural analysis of retroviral proteinases (in the next section). It seemed best to postpone accounts of work towards vaccines and new antiviral agents: both of these are enormously active areas, but our judgement is that they are not at a stage where description via published papers is likely to have lasting validity.
3'-Azido-Y-deoxythymidine (AZT) remains the only antiviral agent in widespread use against HIV; it is considered to act by way of conversion to the 5'-triphosphate and incorporation by reverse transcriptase (RT) into HIV DNA, where it terminates elongation of the nascent strand. In 1989 the not unexpected finding that AZT chemotherapy can result in the emergence of HIV variants resistant to the drug became a documented reality (although attempts to select AZT-resistant strains in tissue culture have not succeeded ; Larder et al., 1989a, b) . Larder et al. (1989a) measured AZT sensitivities of HIV isolates using a plaque inhibition assay in HeLa cells expressing the receptor protein CD4. Isolates from individuals who had not been exposed to AZT exhibited a narrow range of sensitivity, with IDs0 values around 0.03 laM. Isolates from AIDS patients under AZT therapy mostly showed increased resistance; for some of these the ID5o was raised 100-fold. AZT-resistant strains did not show marked changes in sensitivity to other nucleoside analogues. The emergence of these strains was not correlated, on the data available, with any pronounced change in the progress of disease; thus, the implications for treatment are at present unclear.
The presumptive target for mutation to AZT resistance is, of course, RT. However, Larder et al. (1989a) were not able to demonstrate any significant biochemical changes in utilization of AZT triphosphate by the enzyme. In a subsequent paper, Larder & Kemp (1989) examined the sequences of RT genes. Five pairs were analysed, each from an AZT-sensitive, pre-therapy isolate of HIV and from a later, resistant isolate. Each pair showed 14 to 17 amino acid differences between the two RT sequences. The highly resistant isolates all contained specific changes at four loci, whereas isolates of intermediate resistance showed only some of these changes. Larder & Kemp then demonstrated directly that these changes are the determinants of AZT resistance, by constructing an infectious clone of HIV containing only these mutations; this virus exhibited high resistance to AZT. Curiously, however, again no pronounced biochemical changes in RT were noted.
Retroviral proteinases
HIV and other retroviruses encode a proteinase, which is expressed as part of the gag-pol or gag polyprotein and is then responsible for maturational cleavages of the polyprotein in the nascent virus particle. In 1989 several papers reported proteinase three-dimensional structures from X-ray crystallography, the first such analyses for any retroviral protein. This work has the ultimate objective of understanding the structure of the enzyme and interactions with its substrate in sufficient detail to allow rational design of specific inhibitors and antiviral agents. Miller et al. (1989a) reported a structure for the proteinase of Rous sarcoma virus (RSV); both Navia et al. (1989) and Lapatto et al. (1989) reported structures for HIV-1 proteinase; and Wlodawer et al. (1989) reported a structure for a synthetic HIV-1 proteinase (in which the cysteine residues were replaced by c~-amino-n-butyrate). The material for these analyses was obtained by three methods: the RSV enzyme was extracted from virions; Navia et al. and Lapatto et al. utilized Various, studies, including the crystallographic analyses, indicate that the active form of the proteinase is a dimer (see also, for instance, Meek et al., 1989) . As had previously been proposed, the retroviral proteinases can be seen from their folding pattern to belong to the family of aspartic proteases, such as pepsin; these are so called because their active site contains two essential aspartate residues, each in the characteristic sequence Asp-Thr(or Ser)-Gly. However, the 'classical' aspartic proteinases contain sequences equivalent to the retroviral dimer within a single larger polypeptide chain. A model for the HIV proteinase structure proposed in 1987 turns otit to be largely correct (Pearl & Taylor, 1987) .
The retroviral proteinase has a pronounced cleft between the two subunits, which contains the active site. The cleft is partly closed by two 'flaps' consisting of polypeptide hairpins. Extensive mutational studies on HIV proteinase, carried out in E. coli, have delineated three regions of the polypeptide particularly susceptible to mutations which destroy enzymic activity. These are all located around the cleft and include the active site and the flaps (Loeb et al., 1989a , b). Miller et al. (1989b reported the structure of a complex between the HIV proteinase and a substrate-related oligopeptide inhibitor. Extensive contacts were visible between the substrate and the enzyme, and the binding involved pronounced movements within the protein molecule, particularly in the flaps. These closed over the occupied active site, presumably stabilizing substrate interactions and excluding water.
Work on the HIV proteinase has thus reached a very encouraging stage and there is good reason to think that development of proteinase inhibitors with useful antiviral activity should now be a feasible goal.
Nucleotide sequence analyses of viral genomes
In this section we discuss the nucleotide sequences of viruses from three families of segmented genome RNA viruses (arenaviruses, bunyaviruses and reoviruses) which were completed for the first time in 1989, and also report on the completion of the influenza C virus sequence.
The Arenaviridae include the well studied lymphocytic choriomeningitis virus (LCMV) and notable human pathogens such as Lassa fever virus and the agents causing South American haemorrhagic fevers, Junin and Machupo viruses. The arenavirus genome comprises two segments of single-stranded RNA, designated L (large) and S (small). Previous studies had shown that the S segment encodes the nucleocapsid protein (NP) and a precursor to the virion glycoproteins (GPC) in an ambisense coding arrangement, i.e. the 3' half of the S segment encodes NP in the complementary RNA, and as such is negative-sense, whereas the 5' half of the S segment is in the coding sense for GPC. Each polypeptide is translated from a separate subgenomic mRNA. There is an intergenic region in the S RNA which could form a hairpin structure and may be involved in controlling transcription of the mRNAs (reviewed by Bishop & Auperin, 1987) . In 1989 the L RNA segments of two arenaviruses (LCMV and Tacaribe virus) were sequenced. The L segment encodes, in the complementary RNA, a large protein (Mr ~> 250000; 2210 amino acids in both viruses) which is thought to be the viral transcriptase; gross homology to other negative strand virus polymerases was not apparent though the two arenavirus proteins showed 42% similarity (Iapalucci et al., 1989a; . Both LCMV and Tacaribe virus L segments also encode a small protein, in an ambisense arrangement, at the 5" end of the RNA (Iapalucci et al., 1989b; . These proteins (which are 90 amino acids in length for LCMV and 95 amino acids for Tacaribe virus) are relatively rich in Cys residues and contain 'zinc finger' sequences. Indeed the LCMV protein, termed the Z protein, was shown to bind Zn z+ by a Western blotting approach . A subgenomic mRNA species corresponding to the Z protein coding region of the L RNA of each virus was identified in infected cells, and also in virions in the case of LCMV. The Z protein is postulated to be an RNA-binding protein which may play a regulatory role in transcription.
The total length of the arenavirus genome is about 10.6 kb. Because both RNA segments display ambisense coding strategies strictly speaking we should no longer class them as negative strand viruses.
The first complete sequence of a member of the Bunyaviridae was obtained in 1989. The Bunyaviridae family includes in its five genera the viruses causing Rift Valley fever, Crimean-Congo haemorrhagic fever and haemorrhagic fever with renal syndrome. The prototype of the family and of the Bunyavirus genus is Bunyamwera virus. The bunyavirus genome comprises three segments of negative-sense RNA (designated L, M and S) and encodes four structural and two non-structural proteins. Elliott (1989 a, b) provided the sequences of the Bunyamwera virus S and L segments; the sequence of the M segment had been published previously (Lees et al., 1986) . The entire genome contains 12 294 bases of which 576 (4-7%) do not code for polypeptides. The S segment encodes the nucleocapsid protein, N, and a nonstructural protein, NSs, in overlapping reading frames. The Bunyamwera virus N and NSs proteins could be readily aligned with those encoded by other viruses in the Bunyavirus genus, and some regions of the proteins were strongly conserved, suggesting they may be of functional significance (Elliott, 1989a) . The L RNA segment encodes the minor virion component, also termed L, which is thought to be the transcriptase. The L protein is 2238 amino acids in length (Mr 259000) and no extended regions of homology were detected when compared to the L proteins of arenaviruses, paramyxoviruses or rhabdoviruses; a region of weak homology was observed with influenza virus PB1 protein (Elliott, 1989b) . This region aligns with the conserved motifs observed in all RNA polymerases, which are discussed further below. Determination of the genomic sequence of influenza C virus was completed in 1989, by Yamashita et al. (1989) . Thus, for the orthomyxoviruses we now have complete sequences for influenza A, B and C viruses. The influenza C virus genome consists of seven RNA segments, in contrast to the eight segments for A and B viruses (influenza C virus encodes one virion glycoprotein, while types A and B each encode two). The genome complexity of the C virus is t 2 905 nucleotides compared to 13588 for an influenza A virus, or 14640 for an influenza B virus. The complete sequence data confirm the evolutionary relatedness of the three influenza virus types: influenza C virus is more closely related to influenza B than to A influenza virus, but influenza A and B viruses are more similar to each other (Yamashita et aL, 1989) .
The data supplied by Yamashita et al. concerned the three largest RNA segments of the influenza C virus genome, which encode the three polymerase proteins. RNA segment 1 encodes the equivalent of the influenza A and B virus PB2 protein and shows 25% amino acid identity; RNA 2 encodes the PB1 protein which is more conserved (40~ identity of amino acid residues with the influenza A and B virus proteins); RNA 3 encodes the probable equivalent of the acidic PA protein of influenza A and B viruses (25 ~ sequence identity noted), but the influenza C virus product is termed the P3 protein as it is weakly basic at neutral pH.
Next in this section we consider the completion of the first genome sequence for a member of the Reoviridae, that of bluetongue virus in the Orbivirus genus. Bluetongue is an arthropod-transmitted disease of ruminants that is of economic importance in Africa, Australasia and the United States. The genome comprises 10 segments ofdsRNA designated L1 to 3, M4 to 6 and $7 to 10. In the virion these are contained within two shells of protein. With the publication of data on the $8 and $9 segments by Fukusho et al. (1989) , the entire bluetongue virus genome has now been cloned and sequenced by P. Roy and her colleagues (for a review, see Roy, 1989) . The genome comprises 19218 base pairs, and the individual segments range from 822 to 3954 base pairs (Table 1) . Each RNA segment has conserved 5' (GUUAAA) and 3' (ACUUAC) terminal sequences, and each segment encodes a single polypeptide: there are seven structural polypeptides and three non-structural polypeptides. Their coding assignments and properties are summarized in Table 1 . Of note is the coding arrangement in segment S10, which encodes the non-structural protein NS3. Two forms of NS3 are recognized, NS3 and NS3a; by cloning the S10 cDNA into a baculovirus vector it was shown that these are translated from either of two inframe initiation codons, generating products of Mr 25.6K and 25K (French et al., 1989) . The functions of these non-structural proteins are not known.
The completion of the sequence of the bluetongue virus genome and the availability of cloned cDNAs represent a significant step in the rational design of diagnostic probes, and perhaps control measures, for this important veterinary pathogen.
Evolutionary relatedness of RNA-dependent polymerases
As the result of sequence determinations of viral genomes, including those just described, sequences of a number of classes of RNA-dependent polymerases are now known. This section deals with possible evolutionary and functional relationships among these enzymes. Mention has been made previously of sequence comparisons among negative strand virus polymerase (L) proteins. When the sequences of a number of rhabdovirus and paramyxovirus polymerase proteins were compared, low but persuasive similarities were noted between the L proteins of these families (reviewed in Hull & McGeoch, 1989) . However, these similarities are not apparent in the corresponding proteins of arenaviruses and bunyaviruses (which are of a similar size to the rhabdo-and paramyxovirus L proteins). Poch et al. (1989) have made an extensive and sophisticated computer analysis of RNA-dependent RNA polymerases of positive, negative and double-stranded RNA viruses and RNA-dependent DNA polymerases encoded by retroid elements. In total 80 sequences were analysed. The authors identified four consensus motifs, in the same linear arrangement in all polymerases examined, which spanned a region of 120 to 210 amino acids. This region contains four strictly conserved amino acids and 18 conservatively maintained residues and has been dubbed the 'polymerase module'. The linearity of the motifs in these divergent molecules suggests they may cooperate, after folding of the protein, to form an ordered domain. Secondary structure predictions suggest that the invariant amino acids are in, or close to, tight turns and perhaps the orientation of these residues is crucial for template recognition or a catalytic event.
One of the motifs recognized by Poch et al. corresponds to the Tyr-Gly-Asp-Asp element noted by Kamer & Argos (1984) as being conserved among many RNA polymerases. The more extensive analysis of Poch et al. however shows that only the Asp-Asp dipeptide is universally maintained, with an important exception: in all the polymerase proteins of unsegmented negative strand viruses the second Asp residue is changed to Asn; all these virus polymerases therefore show Gly-Asp-Asn in this motif. By comparison, all the segmented negative strand viruses show Ser-Asp-Asp at this position. The only other instance of the Asp to Asn change is in the putative reverse transcriptase of a Chlamydomonas species.
The study by Poch and colleagues provides compelling evidence that all the investigated RNA polymerases, both viral and non-viral, are descendants from an ancestral genetic element specifying a polymerase activity. Examination of the compared sequences suggests that the ancestral polymerase was intermediate in sequence between retrotransposons and positive strand RNA viruses and that the polymerases evolved separately into those with DNA-template and those with RNA-template specificity. These speculations will no doubt fuel much debate in the future. On a more concrete level, the alignments given by Poch et al. establish domains of RNA polymerases that can be dissected in fine detail by site-directed mutagenesis.
Towards genetic manipulation of negative strand viruses
An important goal in current research on negative strand viruses is to establish methods for recovering viable virus from molecularly cloned DNA copies of genomic sequences, so allowing full application of recombinant DNA technology to this class of viruses. Such systems have been available for positive strand viruses for some time. In 1989, two papers from P. Palese's group opened the way to making defined nucleotide alterations in the influenza virus genome. Parvin et al. (1989) reported the first definition of a negative strand virus promoter. Influenza virus polymerase was prepared free of viral RNA from purified virions and used to copy short synthetic RNA templates. Templates containing the T-terminal sequences of genomic (negative sense) RNA were efficiently copied, and the promoter element was mapped to the terminal 15 nucleotides. Although the terminal sequences of the authentic influenza virus genome segments are complementary, so that panhandle-containing RNAs are found in virions and in intracellular ribonucleoprotein complexes (Hsu et al., 1987) , only the 3" terminus was required for efficient transcription. The polymerase preparation was also shown to transcribe full-length influenza virus genome segments in vitro. Perhaps surprisingly the virion-derived polymerase preparation copied a complementary (positive sense) RNA template inefficiently, suggesting that the polymerase may be modified during infection to recognize the slightly different promoter sequence at the 3' terminus of positive sense RNA.
In a subsequent paper, Luytjes et al. (1989) exploited this system to package a foreign gene into influenza virions. A plasmid was constructed ,containing the chloramphenicol acetyltransferase (CAT) gene flanked by the Y-and 5'-terminal untranslated sequences from influenza virus genome segment 8. RNA was synthesized in vitro using T7 RNA polymerase, equivalent to the negative strand of the CAT gene, and this was added to the influenza virus polymerase preparation and transfected into MDCK cells. After superinfection with influenza virus, CAT activity was detected in cell extracts. Supernatant virus from these cells was used to infect other cells and CAT activity was again detected, indicating that the hybrid RNA was packaged into virions. Virus containing the CAT gene could be passaged several times. These experiments are a significant step towards the goal of manipulating authentic influenza virus genes.
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We cannot leave this subject, however, without mentioning a 1990 publication. Recently Ballart et al. (1990) have very impressively succeeded in rescuing infectious measles virus from a DNA clone, using a cell line persistently infected with a defective measles virus as a source of replication proteins. No doubt 1990 will bring forth further examples, which can be discussed more appropriately in the next Highlights review.
Poxvirus genes and proteins
Activities in sequencing fragments of poxvirus genomic DNAs continue to yield a rich harvest of genes which encode proteins recognizably related in their amino acid sequences to known cellular or other non-poxvirus proteins. It has, of course, long been recognized that poxviruses have to supply many enzymic functions for expression and replication of a DNA virus in a cytoplasmic location.
In a number of papers, G. L. Smith and his colleagues described genes found during an extensive sequencing exercise of a region near the right end of vaccinia virus DNA in SalI fragments F and G (Smith et al., 1989a, b, c; Howard & Smith, 1989; Kerr & Smith, 1989) . Probably the most interesting was an open reading frame (ORF) of 552 codons in SalI F, termed 15R. The encoded amino acid sequences of 15R turned out to be closely related to the sequences of yeast DNA ligases, and it was shown that the gene was expressed early in infection (Smith et al., 1989b) . In further work, Kerr & Smith (1989) detected the gene product as a protein of apparent M r 61000. When incubated with [c~-32p]ATP this yielded a labelled covalent complex with characteristics expected for a ligase-AMP intermediate.
An increase in DNA ligase activity in cells infected with vaccinia virus had previously been reported but ascribed to a cellular enzyme. The 1989 papers represent the first description of a ligase gene in the genome of a eukaryotic virus, and also the first sequence for a ligase functioning in higher eukaryotic cells. There is as yet no direct information on the role of the ligase in viral DNA metabolism. In principle it could be involved in replication, recombination or repair. The first of these could be regarded as the most likely, and this has implications for models of vaccinia virus DNA replication, in particular since one current model does not involve any ligase action.
In another paper, Smith et al. (1989a) reported that vaccinia virus SalI F ORF 13R shows strong similarity in encoded amino acid sequence to yeast thymidylate kinase. It was demonstrated that this gene is expressed early in infection, but the encoded protein has not yet been identified nor have supporting enzyme assays been reported. Poxviruses were not previously suspected to encode a thymidylate kinase (distinct from the well known thymidine kinase); however, it now appears likely that the virus supplies both these enzymes to catalyse the first two stages in salvage phosphorylation of thymidine for use in DNA synthesis.
An interesting contrast can now be seen with the case of herpesviruses, where the so-called thymidine kinase (TK) of HSV has a broader catalytic activity, also phosphorylating deoxycytidine and thymidylate. It turns out that the HSV TK amino acid sequence shows some similarities to the thymidylate kinases of yeast and vaccinia virus (probably indicative of an evolutionary relationship) but not to poxvirus or eukaryotic thymidine kinases (Robertson & Whalley, 1988; Smith et al., 1989a) .
Apart from these examples for enzymes of DNA and nucleotide metabolism, other poxvirus genes reported in 1989 whose proteins are recognizably related to nonpoxvirus proteins included two presumptive vaccinia virus protein kinases (Howard & Smith, 1989; Traktman et al., 1989) , two presumptive vaccinia virus serine protease inhibitors (serpins: Kotwal & Moss, 1989; Smith et al., 1989c) and the second largest subunit of cowpox virus RNA polymerase (Patel & Pickup, 1989) .
Finally, there is the case of the 'pseudoproteases' reported for vaccinia virus and for orf virus (Slabaugh & Roseman, 1989; Mercer et al., 1989) . This subject is intriguing but a little involved: the terms 'protease-like domain' or 'pseudoprotease" describe the finding in certain retrovirus genomes of a coding sequence which was apparently distantly related to the proteinase gene (see section on retroviral proteinases) but lacked essential elements of the proteinase catalytic site (McClure et aL, 1987) . In one lineage of the oncoviruses the pseudoprotease coding sequence is adjacent to the proteinase gene, and it is proposed that it originated there by duplication. However, in certain lentiviruses (not including HIV), the pseudoprotease coding sequence is at a distal site within the pol gene, and this is thought to be the result of a recombinational transfer from an oncovirus. The new examples in two poxviruses presumably also represent translocations. It is not clear from the descriptions whether the orf virus and vaccinia virus instances represent corresponding genomic locations. Since the pseudoprotease reading frames have remained open despite extensive mutation it seems certain that the protein does have a functional role, but this remains completely obscure at present.
Plant virus gene expression
Geminiviruses are plant viruses with circular single-stranded DNA genomes, which fall into three subgroups. Members of subgroups A and B are leaf hoppertransmitted and have monopartite genomes, those of subgroup A infecting monocotyledonous plants and those of subgroup B dicotyledonous plants; members of subgroup C are whitefly-transmitted and have bipartite genomes. Transcription of members of all three groups has been shown to be from both the virion-sense and complementary DNA. This bidirectional transcription is initiated in one region and terminates on the opposite side of the genome. Sequencing of two members of the subgroup A, digitaria streak virus (DSV) (Donson et al., 1987) and wheat dwarf virus (WDV) (MacDowell et al., 1985; Woolston et al., 1988) has shown that there are two overlapping ORFs in the complementary strand which correspond to, and have amino acid homology with, one ORF in subgroup C geminiviruses. Up to five RNA species were found to be transcribed from the complementary DNA strand of DSV (Accotto et al., 1989) . Detailed transcript mapping revealed evidence for splicing of one of the transcripts, which would fuse the two ORFs. There was also an unspliced RNA species covering both ORFs, from which presumably only the upstream ORF would be translated. The authors suggested that the extensive overlapping of spliced and unspliced RNAs could indicate that initiation and splicing of transcripts is temporally regulated. Transcription on the complementary strand of WDV was studied by PCR and by mutagenesis (Schalk et al., 1989) . Two species were found in cDNA synthesized by PCR using primers bracketing the putative intron; they corresponded to the sizes expected for formation from unspliced and spliced RNAs. Joining of the two ORFs by deletion of the putative intron or by frameshift mutation did not prevent replication of the virus in suspension cell culture. These reports are the first of splicing occurring naturally in the expression of plant viruses.
Caulimoviruses are plant-infecting pararetroviruses (viruses that replicate by reverse transcription, do not integrate the viral DNA into the host genome and encapsidate the DNA phase of the replication cycle: Temin, 1989; . The genomic DNA is circular and double-stranded, and contains seven ORFs (designated I to VII) all in the same orientation. Two well characterized transcripts are found in infected cells: a 35S species of greater than genome length, which comprises the template for replicative reverse transcription, and a 19S species thought to be the mRNA for ORF VI. A separate mRNA for ORF V, encoding RT, may also exist. Since the 35S transcript initiates upstream of ORF VII, it presumably acts as mRNA for this ORF. However, no separate mRNA species have been detected for ORFs I, II, III and IV. Two 1989 papers investigated the mechanism of expression in these genes, in cauliflower mosaic virus (CaMV; Bonneville et al., 1989) and figwort mosaic virus (FMV; Gowda et al., 1989) .
Plasmid constructs were made with reporter genes (CAT or fl-glucuronidase) downstream of the viral gene VII. After introduction into plant protoplasts, these gave efficient expression of the reporter gene only in the presence of the viral genome. This trans-activation effect mapped to gene VI and could be effected by coelectroporation with constructs which contained the gene VI ORF together with its transcription control sequences. CaMV could trans-activate constructs with an upstream FMV viral ORF and vice versa. Mutagenesis indicated that it was the polypeptide product of gene VI that was responsible. Thus, it appears that expression of ORFs VII, I, II, III and IV is from a single RNA species, the 35S transcript, and that the ORF VI protein acts to allow translation of the distal ORFs, I to IV. This is a highly unusual situation in eukaryotic gene expression. These findings give another function to the gene VI product, which had previously been implicated in the cytoplasmic reverse transcription phase of viral replication.
Modulation of host cell behaviour by adenoviruses
The most easily understood categories of viral gene functions are those concerned with control of virus gene expression, replication of the virus genome and virion structure. Other classes of genes are evidently involved in modulating the response to virus infection of the infected cell or the whole organism, often in subtle ways. This section describes such phenomena in adenovirus systems.
The functions of the proteins encoded by the E3 transcriptional unit of human adenoviruses are mostly obscure. The region is maintained among adenoviruses but is non-essential for virus growth in tissue culture. Judging from the DNA sequences and patterns of spliced mRNAs, this 3 kbp region might encode as many as nine proteins. The best characterized of these is a 19K glycoprotein of adenovirus 2, which is known to interact in the endoplasmic reticulum with nascent HLA type 1 antigen to prevent its transport to the cell surface, thus avoiding display of viral antigens on the cell surface and subsequent response by the immune system. Using the cotton rat as a model of pneumonia with adenovirus types 2 and 5, Ginsberg et al. (1989) examined the role of the E3 region in pathogenesis. Mutants deleted for 19K glycoprotein coding sequences gave markedly increased inflammatory response, whereas mutants with deletions in other parts of the E3 region did not exhibit pronounced changes in the course of infection.
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The example of the 19K glycoprotein gave rise to the thought that other E3 proteins might also have roles in modulation of host processes, and two more E3 proteins have now been assigned such roles. The product of the distal reading frame in the E3 region is a 14.7K protein, recently detected in infected cells (Tollefson & Wold, 1988; Wong et al., 1988) . Gooding et al. (1988) have implicated the 14.7K protein in protection of infected cells against killing by tumour necrosis factor (TNF), which is a peptide hormone produced by macrophages and monocytes in response to inflammatory stimuli and is thought to have an antiviral role. Gooding et al. showed that cells infected with wild-type adenovirus 5 are not lysed by TNF, but that E3 deletion mutants are, and that this sensitivity correlated with absence of the 14.7K protein. Duerksen-Hughes et al. (1989) reported the complementary result, that sensitivity to TNF correlates with expression of the adenovirus transactivating protein E1A.
In another paper from the same group, Carlin et al. (1989) demonstrated that another E3 protein, of Mr 10.4K, can react with molecules of epidermal growth factor receptor (EGFR) present in infected cell membranes, and that this results in the internalization and degradation of EGFR. The 10.4K protein is not a homologue of authentic growth factor (unlike hormonelike proteins specified by poxviruses), and the mechanism of its action is at present unknown. Although the significance of this last finding for adenovirus infection in vivo remains nebulous, the three examples available are consistent with the E3 proteins having a variety of roles in subverting cellular responses to virus infection. Continued study of this system could well provide unique insights into the repertoire of such responses.
Mechanisms of cell transformation by DNA viruses
In many human tumours the so-called retinoblastoma gene (RB1) is damaged. Thus RB1 has the properties of an 'anti-transformation' gene and it is likely that the encoded protein, termed pl05-RB, has an important role in the control and limitation of cell proliferation, although the mechanism of this involvement is unknown (see Hong et al., 1989; Horowitz et al., 1989) . In the last 2 years evidence has accumulated for three groups of DNA viruses that their activities in transforming cells may include interaction with pl05-RB. DeCaprio et al. (1988) showed that the large T antigen of simian virus 40 (SV40) can complex with pl05-RB, and Whyte et al. (1988) obtained a similar result for the E1A protein of adenovirus 5. Neither of these viruses is considered to be associated with human cancer, although they are used in model systems. Dyson et al. (1989) demonstrated an equivalent result for human papillomavirus (HPV) type 16, which has a major association with human uterine cervical carcinoma. They observed a complex between pl05-RB and the viral E7 protein (which is necessary and sufficient for transformation ; Phelps et al., 1988) . The E7 protein, large T and E1A share local sequence similarity near their N termini, in a region known to be necessary for pl05-RB binding .
The work on HPV-16 was extended by Mtinger et al. (1989) to a number of other papillomaviruses. E7 proteins from other HPV types also bound pl05-RB, with the tightness of binding correlating with malignant potential. Mfinger et al. were also able to detect the complex in an HPV-16-transformed keratinocyte line. These findings are consistent with the three groups of viruses transforming cells at least in part through interference with pl05-RB function.
Mtinger et al. also noted that a complex was not detectable using E7 protein of bovine papillomavirus type 1 (BPV-1), which differs in its N-terminal sequences from the HPV E7s. However, a distinct transforming mechanism was outlined by the work of Martin et al. (1989) on the E5 protein of BPV-1. This is a small membrane-anchored species previously known to have transforming activity. Martin et al. showed that the E5 protein could interact with cell surface growth factor receptors to induce activity in the apparent absence of their normal ligand and increase activity in the presence of ligand. In addition, the BPV-1 protein acted to prevent turnover of receptor (these actions are thus opposite to those described in the previous section for adenovirus E3 10-4K protein).
Virion structures
This section deals with three icosahedral capsid structures published in 1989, for foot-and-mouth disease virus (FMDV), bean pod mottle virus (BPMV) and herpes simplex virus type 1 (HSV-1).
Acharya et al. (1989) reported X-ray crystallographic determination of the structure of FMDV at 2.9 A resolution. FMDV is assigned to the Aphthovirus genus of the Picornaviridae, and completion of the FMDV structure means that high resolution virion structures are now known for members of all four genera of the Picornaviridae. Since the first structures were published in 1985, study of these viruses has been transformed by the structures' availability.
The basic architecture found with other picornaviruses holds also for FMDV, but a number of the surface features of FMDV were not seen previously. These include a channel at the fivefold axis which completely penetrates the capsid wall and a structure on the threefold axis which probably binds a Ca 2÷ ion (Ca 2+ is known to be required for cell attachment). Most interestingly, there is no counterpart of the 'canyon' or 'pit', the major depression found in the surface of other picornaviruses which probably contains cell receptor binding sites. Instead, the part of the VPI protein containing the cell attachment site (and also the major neutralizing epitope) is a loop protruding from the capsid surface. The loop appears disordered in the electron density map, and it seems probable that this represents a genuine variability of three-dimensional structure rather than an artefact of analysis. Within the loop is the sequence Arg-Gly-Asp, which is involved in attaching FMDV to cells, and is also the attachment sequence recognized by a number of normal cell surface proteins .
The cell attachment apparatus of FMDV is thus antithetical in design to those of other picornaviruses, being exposed on a surface protrusion rather than located in a depression. The latter strategy has been seen as affording protection from antibodies, while Acharya et al. rationalize the FMDV strategy as possibly 'camouflaging' a small constant binding region within surrounding variable sequences.
In the picornavirus structures so far determined, no component of ordered structure in the genomic RNA has been visible; until 1989 this was also true for the similar icosahedral structures of RNA plant viruses. However, a most interesting analysis has now been published for BPMV by Chen et al. (1989) . BPMV is a comovirus, whose genome consists of two separately encapsidated RNA species. Virions containing only the smaller RNA (of 3.5 kb) were crystallized and the structure was determined at 3.0 A. The capsid architecture is similar to that seen with picornaviruses (suggesting an evolutionary relationship). However, a novel feature was that electron density comparable in magnitude to that representing the capsid proteins was present inside the capsid, and could be modelled convincingly as a seven nucleotide portion of RNA plus a further section of four less well defined nucleotides.
Because of the icosahedral symmetry imposed in solving the capsid structure, the RNA chain appears in the complete structure as a trefoil figure around each threefold axis, and it is not possible to examine any longer range path of the nucleotide chain. Since the complete particle has 60 asymmetric units, the polynucleotide visualized represents 660 nucleotides, about 20~ of the RNA molecule. The observed RNA segment lies in a shallow hydrophilic pocket in one of the virion proteins, held by electrostatic and van der Waal's forces, which are not base-specific. This is a fascinating new departure in structural analysis of small icosahedral RNA viruses, although it remains to be seen whether it will have general implications beyond BPMV.
The last structure treated in this section is the capsid of HSV-1, which Schrag et al. (1989) examined by methods of cryoelectron microscopy to a resolution of about 40 A. The HSV-1 capsid is a larger and more complex object than those described above (1250/k in diameter, compared with 300 A). The complete virion consists of the icosahedral capsid, a surrounding amorphous proteinaceous layer termed the tegument and a lipid membrane carrying surface glycoproteins, the whole structure having a diameter near 2145 A. Cryoelectron microscopy of vitrified, unfixed samples and computer image processing techniques have been used to obtain threedimensional structures of a number of viruses at intermediate resolution. The work of Schrag et al. on HSV-1 represents the extension of this approach to the largest capsid yet reported. It has yielded a greatly enhanced view of the organization of the HSV-1 capsid surface, together with information on an inner icosahedral layer.
The outermost shell (between radii of 425 A and 625 A) is an icosahedron of 162 capsomeres. The 12 capsomeres at the fivefold axes are now seen to be fivesided spikes with a hollow core, and the other 150 capsomeres six-sided, hollow spikes. The masses of the two types of spike are consistent with them being composed of five and six molecules, respectively, of the known major capsid protein. The bases of the spikes are connected by a layer of unresolved structure. Inside the particle, two elements were distinguished. Below a radius of 310 A is material of unresolved structure which must be the genomic DNA, together with any associated proteins. Between 310 A and 425 A is an inner icosahedral shell with a distinct geometry from the outer icosahedron. The protein composition of this is unknown.
Part of the way ahead in analysis of herpesvirus capsid structure must involve better localization of protein species. Newcomb & Brown (1989) reported the use of low energy ion plasma to degrade HSV-1 capsids in such a way that the outermost layers were destroyed first. Analysis of the kinetics of removal of each protein species then allowed the major capsid protein and two others to be classified as surface structures, while another three behaved as internal components.
Viral receptors
The initial interaction between a virus and its target cell is with the viral receptor. Although this step is of fundamental importance in the virus replication cycle few viral receptors have been rigorously identified. In the
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cases where these viral receptors are protein molecules, a powerful molecular genetic strategy has been developed for identifying them. In essence this consists of converting previously resistant cell lines to permissivity by introduction of fragments of foreign DNA, then characterizing the DNA sequences responsible. We report here work on the receptors for two groups of picornaviruses, namely rhinoviruses and polioviruses, and for the retrovirus murine leukaemia virus (MuLV).
There are more than 100 serotypes of human rhinovirus (HRV), most of which utilize the same cell receptor, known as the 'major' rhinovirus receptor. In 1989 papers from three groups (Greve et al., 1989; Staunton et al., 1989; Tomassini et al., 1989) identified the major receptor as intercellular adhesion molecule-1 (ICAM-1) from the following lines of evidence. Monoclonal antibodies (MAbs) which block attachment of HRV recognize a cellular surface glycoprotein of Mr 90K to 95K on permissive HeLa cells and also on mouse cells rendered susceptible to HRV by transfection with human genomic DNA. The purified protein binds HRV in vitro and limited peptide sequencing of the purified protein showed complete concordance with the published sequence of ICAM-1. A cDNA was obtained, either from naturally permissive HeLa cells (Tomassini et al., 1989) or from permissive transfected mouse ceils (Greve et al., 1989) , whose sequence matched that of the ICAM-1 gene. Specific binding of HRV to Vero cells (which are naturally receptor-minus) was observed only after transfection with the cDNA. Lastly MAbs to ICAM-1 were able to prevent HRV causing cytopathic effect in permissive cells. Greve et al. (1989) mapped the receptor to human chromosome 19 by analysis of human-mouse somatic cell hybrids.
ICAM-1 is a member of the immunoglobulin (Ig) superfamily, with a polypeptide backbone of about 55K which is variably glycosylated to yield a heterogeneous protein mass of 76K to 114K (Dustin & Springer, 1988) . The mature protein has five extracellular Ig-like domains. ICAM-I is involved in the adhesion of leukocytes to T cells and functions as a ligand for lymphocyte function-associated antigen-1 (LFA-1). Staunton et al. (1989) showed that MAbs to ICAM-1 which blocked this interaction also blocked HRV binding, whereas another MAb to a different epitope on ICAM-I, which did not affect LFA-1 interaction also failed to block HRV binding. This suggests that the site for interaction of LFA-1 on ICAM-1 overlaps the site for HRV contact. Mendelsohn et al. (1989) identified the receptor for poliovirus, and showed that this too was a member of the Ig superfamily. Previously these workers had transfected mouse L cells with human DNA and obtained a cell line, CM-1, which expressed poliovirus receptors on the cell surface and was susceptible to poliovirus infection (Mendelsohn et al., 1986) . In the 1989 paper polioviruspermissive secondary transformants were isolated using DNA extracted from the CM-1 line and linkage of the poliovirus receptor to human Alu repeat sequences was established using a cloned Alu repetitive probe. This formed the basis for the screening of genomic and cDNA libraries prepared from the secondary transformants. Two cDNA clones so identified were used to transform mouse cells which then expressed the receptor. From DNA sequence data it was predicted that this protein possesses three extracellular Ig domains; the protein backbone of the receptor is 43K or 45K, the difference being due to alternative splicing of the region encoding the cytoplasmic domain. Shepley et al. (1988) have described a MAb which blocks poliovirus infection and recognizes a 100K cellular protein which, like the HRV receptor, maps to chromosome 19. At present it remains unclear as to whether the proteins identified by Mendelsohn et al. and by Shepley et al. are the same.
Both the rhinovirus and poliovirus capsids possess pronounced surface cleft or 'canyon' structures which have been proposed to contain the receptor binding sites. The reports described above suggest that one of the Ig domains of the receptor could fit into the canyon; obviously this is an area for further research. As mentioned above in the section on virion structure, this mechanism contrasts with that employed by FMDV.
The envelope protein gp70 of ecotropic MuLV binds to a component of murine cell membranes. The receptor for gp70 had been mapped previously to the Recl locus on mouse chromosome 5 (Oie et al., 1978; Ruddle et al., 1978) . Albritton et al. (1989) have now identified a cDNA clone which encodes this receptor by a double drug selection procedure. Human EJ bladder carcinoma cells, which are not susceptible to MuLV infection, were transfected with mouse DNA and a gpt gene marker. Colonies selected with mycophenolic acid were infected with a recombinant mouse sarcoma virus expressing resistance to neomycin in an ecotropic envelope; cells resistant to neomycin should also contain the ecotropic virus receptor. A cDNA clone encoding the receptor was isolated from the transfected cells by linkage to mouse repetitive DNA sequences, and mapped to chromosome 5. The cDNA clone contains an ORF of 622 codons, which should encode a protein of Mr 67000. The predicted protein is extremely hydrophobic and could contain as many as 14 membrane spanning domains. No matches were found with any sequences in the databases.
It is interesting that the five recently described proteinaceous viral receptors represent three distinct classes of surface protein: the receptors for HRV, poliovirus and HIV are of the Ig superfamily; EpsteinBarr virus uses the CR2 glycoprotein (Fingeroth et al., 1984) which is the C3D complement receptor and, although a molecule with immunological functions, lacks Ig domains; and the MuLV receptor represents a new type of transmembrane protein, also lacking Ig domains. One imagines therefore that the diversity of viruses may be matched by the diversity of their receptors.
Knowledge of a virus receptor may help in designing antiviral strategies, as illustrated by recent work on HIV. Although an obvious approach would be to block the receptor itself, this could lead to undesirable effects since the receptor molecule presumably plays some role in the normal functioning of the host; in the case of CD4 it is T lymphocyte activation. However, soluble CD4 could be used to bind to the virus and thus prevent infection. Watanabe et al. (1989) reported that daily administration of soluble CD4 to monkeys infected with the related simian immunodeficiency virus had beneficial effects. Other papers have reported modifying the CD4 molecule so that the reagent is not cleared rapidly from the bloodstream, a necessity if this approach is to be considered for AIDS therapy (Capon et al., 1989; Traunecker et al., 1989) .
Spongiform encephalopathies
The molecular nature and mechanism of pathogenesis of the agents responsible for scrapie and other spongiform encephalopathies remain a notable enigma and intellectual challenge. For several years evidence has been tightening for a central role for the 'prion protein' (PrP) in the disease process (see short review by Weissmann, 1989) . In 1989 two papers were published by S. B. Prusiner and his colleagues which increase further our perception of the protein's importance.
The first paper concerns anaysis of the genetics of Gerstmann-Str~iussler syndrome (GSS), which is a very rare human familial disease. It is a neurodegenerative condition with similar pathology to scrapie, and like scrapie it is infectious in that it can be transmitted experimentally to animals by inoculation with preparations of affected tissue. Pursuing the scrapie analogy, Hsiao et al. (1989) examined the PrP genes in two apparently unrelated families affected by GSS and made the very striking discovery that the disease condition is strongly associated with occurrence of a mutated PrP gene. The mutation seen in both pedigrees was the same and resulted in a single amino acid change, of Pro to Leu at amino acid 102. This genotype was not seen in an unrelated control set. Minimally, these results demonstrate a genetic component in susceptibility to GSS and are consistent with a mechanistic role for PrP. However, the fact that the mutations found in two putatively independent pedigrees are identical suggests a much more specific possibility, namely that the disease could be primarily caused by this specifically mutated protein.
More data are awaited with interest.
The second paper comprises an experimental analysis of the PrP gene and its role in scrapie. Scott et al. (1989) produced transgenic mice carrying the hamster PrP gene. On inoculation with a hamster-adapted strain of scrapie agent, these mice exhibited hamster-like susceptibility, distinguishable from control mice and from mice transgenic for an intronless version of the hamster PrP gene. In addition, the mice carrying the complete hamster PrP gene developed a high titre in their brains of the hamster scrapie agent. Thus the hamster PrP gene had both conferred susceptibility and contributed to the synthesis of new strain-specific infectivity.
